Luffa Tablet, Orally Disintegrating
Product Images NDC 60986-2025

2 FDA label images from Marco Pharma International Llc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Luffa (NDC 60986-2025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marco Pharma International Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Luffa N10022

Luffa N10022
Luffa 2 homeopathic combination medicine oral tablets from Marco Pharma International LLC. The label shows dosage instructions, warnings, tamper-evident info, and ingredients including Purging Luffa 6x HPUS and Goldenseal 4x HPUS. The package contains 60 orally disintegrating tablets. NDC 60986-2025-2.*
FDA Label Image

Dd1d7740 C5d3 F0a6 E053 2995a90acb05

Dd1d7740 C5d3 F0a6 E053 2995a90acb05
Luffa orally disintegrating tablet, white and round with a score line across the middle, shown on a green textured background. This human OTC drug is manufactured by Marco Pharma International LLC. The image focuses on a single tablet without visible markings or imprints.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.